See the DrugPatentWatch profile for emend
What Is an Emend Triple Pack?
Emend (fosaprepitant dimeglumine) capsules for chemotherapy-induced nausea prevention come in a triple pack containing three 125 mg capsules. This provides a single-dose regimen: one capsule daily for 3 days, starting on the first day of chemotherapy.[1]
How Is It Used in Treatment?
Administer one 125 mg capsule orally within 1 hour before chemotherapy on Day 1, then one capsule on Days 2 and 3. The triple pack matches this standard 3-day course for adults.[1]
Available Pack Sizes and Pricing
- Triple pack (3 x 125 mg capsules): Common for single-patient use.
- Single 125 mg capsules also sold separately.
Retail prices vary; a triple pack costs around $600-$700 without insurance in the US.[2]
Who Makes Emend and Patent Status?
Merck & Co. manufactures Emend. Key patents on the capsule formulation expired in 2023, allowing generics, but brand triple packs remain available. Check DrugPatentWatch.com for expiration details and generic entrants.[3]
[1] Emend Prescribing Information, Merck.
[2] GoodRx pricing data.
[3] DrugPatentWatch.com.